Latest News

Add to Favorites Subscribe Share
newswise-fb-share-
Press "esc" to clear
Go to Advanced Search
Showing results 4150 of 210125

Article ID: 708529

Endocrine Society CEO honored with Association Leadership Award

Endocrine Society

CEO Update has selected Endocrine Society CEO Barbara Byrd Keenan, FASAE, CAE, as its Professional Society CEO of the Year.

Released:
22-Feb-2019 9:45 AM EST
Open in New Tab
Comment
wau-logo.gif

Article ID: 708526

Chemical added to consumer products impairs response to antibiotic treatment

Washington University in St. Louis

Grocery store aisles are stocked with products that promise to kill bacteria. However, new research from Washington University in St. Louis finds that a chemical that is supposed to kill bacteria is actually making them stronger and more capable of surviving antibiotic treatment.

Released:
22-Feb-2019 9:40 AM EST
Open in New Tab
Comment
TSF.jpg

Article ID: 708522

TSF Announces $951,500 in Funding for Cardiothoracic Surgery Grants for 2019

The Society of Thoracic Surgeons

The Thoracic Surgery Foundation (TSF) has announced 24 new grants totaling $916,500 in support of research and education programs in cardiothoracic surgery.

Released:
22-Feb-2019 8:05 AM EST
Open in New Tab
Comment
NeckHeidi-1.jpg

Article ID: 708521

Babson College Offers Global Symposia for Entrepreneurship Educators in Dubai

Babson College

Babson College offered the latest edition of its Global Symposia for Entrepreneurship Educators (SEE) in Dubai February 18-21, 2019.

Released:
22-Feb-2019 8:05 AM EST
Open in New Tab
Comment

Education

Mich-Scleroderma.jpg

Article ID: 708507

Systemic Scleroderma Treatments: Where Are We Now?

Michigan Medicine - University of Michigan

A new and novel outcome measure is being used to determine effectiveness of new scleroderma treatments. Learn how Michigan Medicine is leading the way.

Released:
22-Feb-2019 5:30 AM EST
Open in New Tab
Comment
prof-freddy-boey.jpg

Article ID: 708520

Freddy Boey appointed Deputy President (Innovation & Enterprise)

National University of Singapore

The National University of Singapore (NUS) today announced that Professor Freddy Boey, Senior Vice President (Graduate Education & Research Translation) will become Deputy President (Innovation & Enterprise) from 1 April 2019. Prof Boey will be responsible for the University’s initiatives and activities in the areas of innovation, entrepreneurship and research translation, as well as graduate studies in this new role. As part of this appointment, Prof Boey will also assume leadership of NUS Enterprise when Dr Lily Chan, CEO of NUS Enterprise, steps down at the end of March 2019. Dr Chan will continue on in an advisory capacity from 1 April 2019.

Released:
21-Feb-2019 11:05 PM EST
Open in New Tab
Comment

Education

Dr.MichaelRodriguez2.JPG

Article ID: 708519

Potential of Strategic Partnerships to Form a Health Equity Network of the Americas (HENA)

University of California, Los Angeles (UCLA), Health Sciences

Recognizing the persistence of health inequities in the Americas, an emerging Health Equity Network of the Americas (HENA) describes its approach to promoting health equity through intersectoral partnerships in a newly released issue of Ethnicity & Disease.

Released:
21-Feb-2019 5:05 PM EST
Open in New Tab
Comment

Law and Public Policy

EAT-logo.png

Article ID: 708516

Academy of Nutrition and Dietetics Congratulates 10 Members Named to 2020 Dietary Guidelines for Americans Expert Advisory Panel

Academy of Nutrition and Dietetics

CHICAGO – Ten members of the Academy of Nutrition and Dietetics, the world’s largest organization of food and nutrition professionals, are among 20 nationally recognized nutrition and health science authorities named on February 21 by the U.S. Departments of Agriculture and Health and Human Services to the government’s new 2020 Dietary Guidelines Advisory Committee.

Released:
21-Feb-2019 5:05 PM EST
Open in New Tab
Comment
CUIMC_RGB.jpg
  • Embargo expired:
    21-Feb-2019 5:00 PM EST

Article ID: 708172

New “Smart Drug” Shows Promise for Metastatic Triple-Negative Breast Cancer

Columbia University Irving Medical Center

A clinical trial at NewYork-Presbyterian/Columbia and other centers found that patients responded to a new “smart drug” for women with an aggressive form of breast cancer.

Released:
15-Feb-2019 11:05 AM EST
Open in New Tab
Comment

Showing results 4150 of 210125

Chat now!